Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INSMED Inc Director's Dealing 2016

Nov 9, 2016

30150_dirs_2016-11-09_4b72bf8c-deb3-4281-94ea-587061c97b13.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2016-11-07

Reporting Person: Schaeffer Orlov S Nicole (SVP, HR & Corp. Svcs.)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-11-07 Common Stock M 37500 $6.96 Acquired 37500 Direct
2016-11-07 Common Stock S 37500 $11.78 Disposed 0 Direct
2016-11-07 Common Stock M 23265 $6.96 Acquired 23265 Direct
2016-11-07 Common Stock S 23265 $11.78 Disposed 0 Direct
2016-11-09 Common Stock M 8009 $6.96 Acquired 8009 Direct
2016-11-09 Common Stock S 8009 $13.25 Disposed 0 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-11-07 Stock Option $6.96 M 37500 Disposed 2023-01-02 Common Stock (37500) Direct
2016-11-07 Stock Option $6.96 M 23265 Disposed 2023-01-02 Common Stock (23265) Direct
2016-11-09 Stock Option $6.96 M 8009 Disposed 2023-01-02 Common Stock (8009) Direct

Footnotes

F1: The price in column 4 is a weighted average price. The prices in these transactions range from $11.75 to $11.91.

F2: Stock options granted under the Company's 2000 Stock Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.